Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...

The Bank of Bahrain and Kuwait (BBK), a premier retail and commercial bank in the Kingdom, has announced an exciting lineup ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2025 Unplugged Medtech and Life ...

Babson's end-to-end BetterWay testing ecosystem, which includes the BD MiniDraw Capillary Blood Collection device as well as Babson's proprietary automated sample preparation and preanalytical ...

Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into ...

Scott Bertram, a director at Becton Dickinson & Co. (NYSE:BDX), recently sold 700 shares of the company's common stock, according to a recent filing with the Securities and Exchange Commission. The ...

Shares of Becton Dickinson & Co. BDX slipped 1.60% to $225.85 Wednesday, on what proved to be an all-around rough trading ...

A new BD will have four new operating segments: medical essentials, connected care, BioPharma systems and interventional.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Total Income amounted to BD 13.816 million during the final quarter of 2024, compared to BD 10.692 million for the same ...

Jeffrey William Henderson, a director at Becton Dickinson & Co (NYSE:BDX), recently acquired 1,500 shares of the company's common stock. The purchase, which took place on February 10, 2025, was made ...

BD recently issued a medical device correction later related to its Bard subsidiary's Rotarex atherectomy system.